Robert Iannone, M.D., M.S.C.E
2020
Compensation breakdown
| Non-Equity Incentive Plan | $450,000 |
|---|---|
| Option Awards | $874,522 |
| Salary | $592,308 |
| Stock Awards | $1,221,479 |
| Other | $11,172 |
| Total | $3,149,481 |
MSCE received $1.2M in stock awards, accounting for 39% of the total pay in 2020.
MSCE also received $450K in non-equity incentive plan, $874.5K in option awards, $592.3K in salary and $11.2K in other compensation.
Rankings
In 2020, Robert Iannone, M.D., M.S.C.E's compensation ranked 3,691st out of 13,090 executives tracked by ExecPay. In other words, MSCE earned more than 71.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,691 out of 13,090 | 72nd |
Division Manufacturing | 1,452 out of 5,618 | 74th |
Major group Chemicals And Allied Products | 548 out of 2,251 | 76th |
Industry group Drugs | 475 out of 1,951 | 76th |
Industry Pharmaceutical Preparations | 358 out of 1,456 | 75th |
Pay ratio
| Robert Iannone, M.D., M.S.C.E's Pay | $3,149,481 |
|---|---|
| Median Employee's Pay | $234,935 |
| Pay Ratio | to 1 |
In 2020, the annual total compensation of Robert Iannone, M.D., M.S.C.E was $3,149,481.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $234,935.
The ratio of Robert Iannone, M.D., M.S.C.E's pay to the pay of median employee was therefore to one.
MSCE's colleagues
We found five more compensation records of executives who worked with Robert Iannone, M.D., M.S.C.E at Jazz Pharmaceuticals in 2020.
2020
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2020
Kim Sablich
Jazz Pharmaceuticals
Executive Vice President and General Manager, North America
2020
Daniel Swisher
Jazz Pharmaceuticals
Chief Operating Officer
2020
Renée Gal
Jazz Pharmaceuticals
Chief Financial Officer
2020
Robert Ianonne
Jazz Pharmaceuticals